دورية أكاديمية

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

التفاصيل البيبلوغرافية
العنوان: Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
المؤلفون: Koeberle, D. *, Dufour, J.-F., Demeter, G., Li, Q., Ribi, K., Samaras, P., Saletti, P., Roth, A.D., Horber, D., Buehlmann, M., Wagner, A.D., Montemurro, M., Lakatos, G., Feilchenfeldt, J., Peck-Radosavljevic, M., Rauch, D., Tschanz, B., Bodoky, G.
المصدر: In Annals of Oncology May 2016 27(5):856-861
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw054